3,300
Participants
Start Date
February 18, 2014
Primary Completion Date
December 20, 2018
Study Completion Date
December 20, 2018
Blood sample collection
Blood samples will be collected at each study visit (Day 0, Month 6, Month 12, Month 24, Month 36 and Month 48) and any time during the study that dengue is suspected. Samples collected at scheduled visits will be tested for anti-dengue antibodies. Samples collected at visits for dengue suspicion will be tested for dengue infection diagnosis.
Data collection
Diary logs will be issued to all subjects at every visit, except Month 48 (Day 0, Month 6, Month 12, Month 24, and Month 36), as required. Any completed diary logs will be verified, as applicable. Subjects will be given a diary log in the event of the occurrence of a symptom that may be associated with suspected dengue.
GSK Investigational Site, Manaus
GSK Investigational Site, Salvador
GSK Investigational Site, Campinas
GSK Investigational Site, Natal
GSK Investigational Site, Rio de Janeiro
Lead Sponsor
Collaborators (1)
Tropical Disease Foundation
OTHER
Goncalo Moniz Research Center
OTHER
Evandro Chagas Research Institute, Bio-Manguinhos Technology and Immunology Institute
OTHER_GOV
GlaxoSmithKline
INDUSTRY